Early registration for GU25 closes on January 8th – ASCO
American Society of Clinical Oncology (ASCO) shared a post on X:
“Early registration for GU25 closes January 8th at 11:59 PM ET.
Don’t miss your chance to access the best rates and join the leading global forum for GU cancer research.
Book today.
Co-sponsored by American Society for Radiation Oncology and Society of Urologic Oncology.”
More posts featuring ASCO.
The American Society of Clinical Oncology (ASCO) is a leading professional organization representing nearly 45,000 physicians and oncology specialists worldwide, dedicated to cancer care.
Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO is committed to advancing cancer research, education, prevention, and high-quality patient care.
Dr. Pedro Barata is the Miggo Family Endowment Chair in Clinical Research and an Associate Professor at University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine in Cleveland, Ohio.
He serves as Director of Clinical Research for the GU Medical Oncology Program and Co-Leader of the Genitourinary (GU) Disease Team. Dr. Barata specializes in treating GU tumors and designing clinical trials, with a research focus on proof-of-concept trials, clinical biomarkers, and genomic-based therapies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023